115
Views
13
CrossRef citations to date
0
Altmetric
Drug Profile

Pioglitazone: beyond glucose control

Pages 1057-1067 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hind Beydoun, Vijaya Kancherla, Laurel Stadtmauer & May Beydoun. (2013) Patterns of use of insulin-sensitizing agents among diabetic, borderline diabetic and non-diabetic women in the National Health and Nutrition Examination Surveys. Gynecological Endocrinology 29:4, pages 350-356.
Read now
Sheila A Doggrell. (2011) Sitagliptin or exenatide once weekly for type 2 diabetes: comparison of the clinical trials. Expert Opinion on Pharmacotherapy 12:13, pages 2055-2067.
Read now

Articles from other publishers (11)

Fatemeh Kheirollahzadeh, Elahe Eftekhari, Marzieh Ghollasi & Payam Behzadi. (2022) Anti-hyperglycemic effects of Eryngium billardierei F. Delaroche extract on insulin-resistance HepG2 cells in vitro. Molecular Biology Reports 49:5, pages 3401-3411.
Crossref
Nitin Vig, Gaurav Kumar Jain, Amit Bhatia & Shruti Chopra. (2022) Rapid and Stable Liquid Chromatographic Tandem Mass Spectrometric Method for Simultaneous Estimation of Pioglitazone, Keto Pioglitazone and Hydroxy Pioglitazone in Human Plasma: Application to Bioequivalence Study. Asian Journal of Chemistry 34:11, pages 3006-3014.
Crossref
Min-Hee Woo, Hye Sun Lee & Jinkwon Kim. (2019) Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study. Cardiovascular Diabetology 18:1.
Crossref
Simon Zhornitsky, Kyla A. McKay, Luanne M. Metz, Charlotte E. Teunissen & Manu Rangachari. (2016) Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Multiple Sclerosis and Related Disorders 5, pages 53-65.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 419 458 .
C. S. Kovacs, V. Seshiah, R. Swallow, R. Jones, H. Rattunde, H. J. Woerle & U. C. Broedl. (2014) Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial. Diabetes, Obesity and Metabolism 16:2, pages 147-158.
Crossref
Azza A. K. El-Sheikh & Rehab A. Rifaai. (2014) Peroxisome Proliferator Activator Receptor (PPAR)- γ Ligand, but Not PPAR- α , Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver . PPAR Research 2014, pages 1-10.
Crossref
Sung-Chen Liu, Kuo-Liong Chien, Chao-Hung Wang, Wei-Che Chen & Ching-Hsiang Cleunghen. (2013) Efficacy and Safety of Adding Pioglitazone or Sitagliptin to Patients with Type 2 Diabetes Insufficiently Controlled with Metformin and a Sulfonylurea. Endocrine Practice 19:6, pages 980-988.
Crossref
N. S. Parfenova & D. A. Tanyanskiy. (2013) ADIPONECTIN: BENEFICIAL EFFECTS ON METABOLIC AND CARDIOVASCULAR DYSFUNCTIONS. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 19:1, pages 84-96.
Crossref
André J. Scheen. (2012) Outcomes and lessons from the PROactive study. Diabetes Research and Clinical Practice 98:2, pages 175-186.
Crossref
Nadir M. Maraldi & Giovanna Lattanzi. 2012. Cytoskeleton and Human Disease. Cytoskeleton and Human Disease 375 409 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.